Bright Minds Biosciences Inc.
DRUG · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $251,575 | $231,588 | $231,183 | $7,062 |
| - Cash | $51,388 | $55,680 | $57,897 | $5,720 |
| + Debt | $141 | $167 | $183 | $119 |
| Enterprise Value | $200,328 | $176,075 | $173,469 | $1,461 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$3,280 | -$3,330 | -$1,603 | -$772 |
| % Margin | – | – | – | – |
| Net Income | -$5,243 | -$2,950 | $50 | -$749 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.74 | -0.63 | 0.011 | -0.17 |
| % Growth | -17.5% | -5,987.9% | 106.3% | – |
| Operating Cash Flow | -$3,504 | -$2,425 | -$1,494 | -$463 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$3,504 | -$2,425 | -$1,494 | -$463 |